Item 5.02 Departure of Directors or Certain Officers; Election of Directors;


          Appointment of Certain Officers; Compensatory Arrangements of Certain
          Officers




Election of New Director

On March 2, 2022, the board of directors ("Board") of Biofrontera Inc. (the "Company") voted to increase the size of the Board from four directors to five directors and appointed Kevin D. Weber to fill the vacancy resulting from such increase. Mr. Weber will serve as a Class II Director to hold office for a term expiring at the annual meeting of the Company's stockholders for fiscal year 2023. Mr. Weber's term as director began upon his appointment at the March 2, 2022 meeting. Mr. Weber does not currently serve on any committees of the Board.

Mr. Weber has not been involved in any related party transaction within the meaning of Item 404(a) of Regulation S-K promulgated under the Securities Exchange Act of 1934, as amended and required to be disclosed herein.

Mr. Weber's compensation will be as provided under the Company's non-employee director compensation policy. Mr. Weber will receive a $35,000 annual retainer for his service as a director, which will be pro-rated for the remainder of the calendar year 2022. If he is appointed to one or more Board committees, he would receive an additional annual retainer.

Amendment to Lübbert Employment Agreement

On March 2, 2022, Hermann Lübbert and the Company entered into an amendment (the "Amendment") to his employee agreement. The amendment is effective as of December 15, 2021 and the key terms of the Amendment are summarized below:

Effective Date. Prof. Dr. Lübbert's employment agreement was amended to remove the conditions for its effectiveness and replaced them with an effective date of December 15, 2021.

Performance. The employment agreement was amended such that Prof. Dr. Lübbert agrees to devote 100% of his working capacity to his duties as the Company's Executive Chairman.

Compensation. Under the Amendment, Prof. Dr. Lübbert's base salary will be $468,500 and he will be eligible to receivea cash bonus of up to 65% of his base salary upon the attainment of performance goals set in advance by the Board. The actual amount of any bonus shall depend upon the level of achievement of set targets, however no bonus shall be paid if the level of target achievement is below 70%.

To the extent that it is not modified by the Amendment, Prof. Dr. Lübbert's Amended Employment Agreement, which was previously filed with the Securities and Exchange Commission, remains in full force and effect.

The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the copy of the Agreement filed as Exhibit 10.1 to this report.

Item 9.01 Financial Statements and Exhibits.

10.1 Amendment to Amended Employment Agreement effective as December 15, 2021


     and dated March 2, 2022 - Herman Lübbert
104  Cover Page Interactive Data File (the cover page XBRL tags are embedded

within the inline XBRL document)

© Edgar Online, source Glimpses